A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

Background: Multiple sclerosis is a chronic inflammatory ... [20] In these patients, cognitive function improved and the brain atrophy rate was significantly slowed. Here, immunomodulatory effects ...

UK researchers have unveiled an innovative artificial intelligence (AI) tool, named MindGlide, designed to interpret and ...

What is Parkinsonism? Parkinsonism is a neurological disorder that affects the movement of the body. It is named after James ...

uhbs.ch Objective The 12-month (M), phase 3, double-blind, randomised TRANSFORMS study demonstrated significant benefits of fingolimod 0.5 or 1.25 mg over interferon β-1a (IFNβ-1a) in patients with ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

William Lindsey, MD, Director of the Division of Multiple Sclerosis and Neuroimmunology at McGovern Medical School, UT Health Houston. But why? (0:39) Share on Facebook. Opens in a new tab or ...

William Lindsey,Director of the Division of Multiple Sclerosis and Neuroimmunology at McGovern Medical School, UT Health Houston. (1:13) Share on Facebook. Opens in a new tab or window Share on ...